Genetic blueprint of complex human diseases, validated markers and therapeutic targets for diagnosis and treatment of schizophrenia, using genome hybrid identity profiling. Based in Evry, France.

Category
Outsourcing
Visits
122
Added
Apr 9, 2026
Rating
(128)
Rate This Site
Advertise herefrom $15.00/day  ·  RON $21.00/day